ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.650
-0.060 (-3.51%)
At close: Sep 25, 2026, 4:00 PM EDT
1.660
+0.010 (0.60%)
After-hours: Sep 25, 2026, 7:30 PM EDT
ProQR Therapeutics Employees
ProQR Therapeutics had 187 employees as of December 31, 2025. The number of employees increased by 21 or 12.34% compared to the previous year.
Employees
187
Change (1Y)
21
Growth (1Y)
12.34%
Revenue / Employee
$112,796
Profits / Employee
-$257,373
Market Cap
232.85M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 187 | 21 | 12.34% |
| Dec 31, 2024 | 166 | 10 | 6.07% |
| Dec 31, 2023 | 157 | 26 | 20.28% |
| Dec 31, 2022 | 130 | -51 | -28.30% |
| Dec 31, 2021 | 182 | 31 | 20.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Lyell Immunopharma | 161 |
| Entrada Therapeutics | 152 |
| Keros Therapeutics | 92 |
| Compugen | 75 |
| Cartesian Therapeutics | 75 |
| Sionna Therapeutics | 59 |
| Pyxis Oncology | 56 |
PRQR News
- 4 days ago - ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor - GlobeNewsWire
- 18 days ago - ProQR Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 18 days ago - ProQR Therapeutics doses first participant in AX-0811 clinical trial - TheFly
- 18 days ago - ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026 - GlobeNewsWire
- 25 days ago - ProQR to Participate in Upcoming Investor Conferences in September 2026 - GlobeNewsWire
- 5 weeks ago - ProQR Therapeutics initiated with a Buy at BofA - TheFly
- 6 weeks ago - ProQR Announces Second Quarter 2026 Operating and Financial Results - GlobeNewsWire
- 6 weeks ago - ProQR Therapeutics Earnings release: Q2 2026 - Filings